Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Higher inflation from tariffs is still expected to flow through the U.S. economy, but Wall Street investors aren’t expecting ...

Round One Corp. (4680.TO) Japan Year Ended March 31 GROUP 2025 2024 Revenue Y177.06 bln Y159.18 bln Operating Profit Y26.24 bln Y24.71 bln Pretax Profit Y23.01 bln Y21.67 bln Net Profit Y15.41 bln Y14 ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Coronado Global Resources is in talks about the possible sale of a minority interest in some of its assets. Coronado said Friday that it hasn't received a binding proposal from any potential investor, ...

SYDNEY--Shares in Insignia Financial rose in early trade after former suitor Bain Capital said it could revive its interest in the Australian wealth manager. The stock jumped as much as 5.1% shortly ...

United has a major hub at Newark Liberty International Airport, and Wall Street wonders just how much the late-spring ...

Baird’s Ben Kallo said he needs to see how QuantumScape plans to make money on its breakthrough EV battery-making technology ...

CorMedix plans to offer $85 million in shares for an underwritten public offering. The stock fell 11%, to $13.38, in after-hours trading. MRC Global is planning to be purchased by DNOW in a $1.5 ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

SYDNEY--Australian supermarket giant Woolworths will close the MyDeal marketplace business it acquired in 2022, citing costs and competition.

INmune Bio shares jumped after the company said it would report top-line data from an Alzheimer's disease drug trial on Monday. The stock rose 78%, to $11.20, after hours Thursday. It closed the ...